Skip to main content

Table 2 Comparison of CT findings between HCC with HBDTT and Hilar CC

From: Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge

Findings

HCC with HBDTT group (n = 58)

Hilar CC group (n = 77)

p

Tumor size (mm), mean ± SD

46.02 ± 27.28 (n = 58)

19.02 ± 10.55 (n = 62)

<  0.001

Parenchymal lesion with intraductal lesion

58(100)

14(18.2)

<  0.001

Intrahepatic bile duct dilation

58(100)

74(96.1)

0.259 (fisher)

CT density

 Precontrast

Hyperattenuation

1(1.7)

0

0.245 (fisher)

Isoattenuation

6(10.3)

4(5.2)

Hypoattenuation

51(87.9)

73(94.8)

 Arterial phase

Hyperattenuation

47(81.0)

53(68.8)

0.111

Isoattenuation

5(8.6)

17(22.1)

Hypoattenuation

6(10.3)

7(9.1)

 Portal venous phase

Hyperattenuation

8(13.8)

30(39.0)

<  0.001

Isoattenuation

1(1.7)

42(54.5)

Hypoattenuation

49(84.5)

5(6.5)

Thickened hilar bile duct wall

5(8.6)

72(93.5)

<  0.001

Vascular tumor embolus

26(44.8)

6(7.8)

< 0.001

Lymph node enlargement

7(12.1)

15(19.5)

0.248

Splenomegaly

20(34.5)

2(2.6)

< 0.001

Ascites

4(6.9)

0

0.068

Esophageal and gastric varices

2(3.4)

0

0.183 (fisher)

Calculus of intrahepatic bile duct

1(1.7)

11(14.3)

0.011